Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FB8H3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,581
Award facts
- Contract value 100% obligated
- $15,580.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $15,580.64 delivery order to Amerisourcebergen Drug Corp on June 12, 2026, for 60-count tablets of Xifaxan 550 mg, with ultimate completion by June 15, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to Department of Defense and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FB8H3?
SPE2DR26FB8H3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 12, 2026.
How much is contract SPE2DR26FB8H3 worth?
The government has obligated $15,581 on SPE2DR26FB8H3.
Is contract SPE2DR26FB8H3 an order under another contract?
Yes. SPE2DR26FB8H3 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FB8H3 competed?
The extent of competition for SPE2DR26FB8H3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award